News from fibrogenesis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

10 Nov, 2020, 14:37 GMT FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform

FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts...


01 Oct, 2020, 16:19 BST FibroGenesis Expands Fight Against COVID-19 In Brazil with International Collaboration

FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs has entered into a clinical collaboration...


21 Jul, 2020, 15:08 BST COVID-19 Fibroblast Based Cell Therapy Candidate Shown to Reduce Lung Scarring in Aggressive Animal Model

FibroGenesis announced today new data supporting use of its PneumoBlast™ product in the battle against COVID-19. Using the widely accepted bleomycin...


01 Jul, 2020, 20:23 BST FibroGenesis Identifies Mechanism Responsible for Blocking COVID19-Like Lung Inflammation

FibroGenesis announced today identification of molecular mechanisms associated with the potent reduction of lung inflammation previously reported by...


21 May, 2020, 15:03 BST FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

FibroGenesis announced today significant efficacy of its PneumoBlast™ product in an animal model of lung inflammation which resembles COVID-19. Mice...


21 Apr, 2020, 14:13 BST FibroGenesis Announces the Filing of its 200th Patent for Fibroblast Cell Therapy Platform

FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts...


01 Apr, 2020, 14:13 BST FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS

FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts...


10 Mar, 2020, 14:13 GMT FibroGenesis Files Patent Using its Fibroblast Cell Therapy for Coronavirus (COVID-19) ARDS

FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts...